QuantiPath Enhances Laboratory Options
QuantiPath, a molecular diagnostics pioneer in pathogen detection and food safety, has announced an exciting expansion of its molecular diagnostics lineup. The company aims to provide laboratories with enhanced à la carte multiplex Salmonella primer and probe options alongside non-multiplex qPCR testing pathways. These advancements mark a significant step in enabling laboratories to customize their assay designs and deployment strategies.
New Multiplex Salmonella Options
The newly introduced à la carte multiplex menu dramatically diversifies the available Salmonella serovar options. This enhancement allows users to tailor their testing panels to specific customer preferences, regulatory requirements, or unique investigative needs. With these expanded choices, QuantiPath's offerings now better complement its existing KPI kits, encouraging more sophisticated multiplex strategies for targeted surveillance and pathogen reduction.
CEO Insights on Expansion
John LoPorto, CEO & President of QuantiPath, expressed enthusiasm about this expansion, stating, "This is our first product line expansion of the year. We have several new products set for release later this year. Some of these enhancements are in direct response to customer requests, while others aim to broaden the markets we serve." This approach highlights QuantiPath's commitment to meeting the evolving needs of its customers.
Introducing Non-Multiplex qPCR Testing
Alongside the multiplex capabilities, QuantiPath now offers non-multiplex qPCR testing options. These tests utilize SYBR® Green-based detection chemistry, which is a preferred choice for straightforward non-multiplex workflows. This option is particularly beneficial when rapid assay deployment and adaptability are essential factors.
Importance of Specific Serovar Identification
According to Dr. Elizabeth Krushinskie, VP-Poultry at QuantiPath, the ability to identify and quantify specific serovars at every step of the production process is crucial. This capability not only enhances the understanding of intervention effectiveness but also contributes significantly to time and cost savings while mitigating risks involved.
Commitment to Laboratory Diversity
QuantiPath's commitment to providing both multiplex and non-multiplex testing strategies showcases its dedication to delivering scalable molecular tools. These tools cater to a diverse range of laboratory needs, facilitating everything from high-throughput screening programs to targeted investigative testing scenarios.
About QuantiPath
QuantiPath is transforming food safety testing with its innovations in precision genetic diagnostics. The company's flagship product, GenoPATHx, stands out as the only rapid test kit that can simultaneously identify and quantify multiple Salmonella serovars. This technology provides unmatched insights into microbial contamination for the food industry. The team at QuantiPath consists of skilled geneticists, microbiologists, and industry professionals committed to ensuring data clarity, boosting consumer safety, and providing operational confidence from farm to fork.
Frequently Asked Questions
What recent enhancements has QuantiPath announced?
QuantiPath has expanded its molecular diagnostics portfolio with new à la carte multiplex Salmonella options and non-multiplex qPCR testing pathways.
How does the new à la carte menu benefit laboratories?
It allows labs to customize their testing panels, tailoring them to their specific needs around customer preferences and regulatory requirements.
What is the significance of identifying specific Salmonella serovars?
Identifying specific serovars helps producers understand which interventions are effective, ultimately saving time and reducing risks.
What new technology does QuantiPath offer for non-multiplex testing?
QuantiPath provides non-multiplex qPCR testing options utilizing SYBR® Green-based detection chemistry.
What is the mission of QuantiPath?
QuantiPath aims to revolutionize food safety through data clarity and operational confidence in microbial testing.